Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Colloidal oatmeal refers to finely ground whole oat kernels that are processed to preserve their biologically active components—primarily polysaccharides like beta-glucans, proteins, lipids including unsaturated fatty acids and ceramide precursors, phenolic antioxidants such as avenanthramides, vitamins like vitamin E, minerals, and saponins. When applied topically in creams or bath additives approved by regulatory agencies such as the FDA for use as "skin protectants," colloidal oatmeal forms a protective film that hydrates dry/irritated skin while reducing inflammation and itchiness associated with conditions like eczema. Its anti-inflammatory effects are largely attributed to avenanthramide polyphenols which inhibit cytokine release from keratinocytes; its moisturizing action comes from water-binding polysaccharides/lipids; additional benefits include antioxidant protection against environmental stressors and support for healthy microbial balance on the skin surface. Colloidal oatmeal does not represent a single molecular entity nor function as a classic drug target but instead acts through multiple synergistic mechanisms provided by its diverse natural constituents.
Colloidal oatmeal acts through several mechanisms due to its composite nature: - Forms hydrophilic film on the skin for moisture retention via beta-glucans and starches. - Reduces inflammation through avenanthramides inhibiting pro-inflammatory cytokines. - Provides antioxidant protection via polyphenols. - Buffers skin pH and supports restoration of the stratum corneum lipid barrier. - Supports growth of beneficial commensal microorganisms on the skin surface.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Colloidal oatmeal.